Navigating the AI Landscape in Health Insurance: Implications and Insights

In a rapidly evolving digital landscape, the intersection of artificial intelligence (AI) and healthcare is under intense scrutiny. A recent public disagreement between billionaire investor Mark Cuban and venture capitalist Marc Andreessen has reignited discussions about the role of AI in medicine, particularly its application within health insurance. Cuban's staunch defense of human doctors against Andreessen's claim that AI has outperformed them has illuminated a critical and often overlooked dimension of AI: its use by health insurers to manage, and sometimes deny, patient claims.

This exchange, which took place in July 2023, coincided with the release of findings from OpenAI's latest model, GPT-5.6, suggesting that AI could potentially provide more accurate medical advice than human practitioners. While Andreessen championed the model's capabilities, Cuban countered that technological advancements in diagnosis do not translate into improved outcomes for patients once their treatment plans reach the hands of insurers. This discussion raises significant questions about the ethical and operational implications of AI in health insurance, especially concerning claims processing and patient care.

Understanding AI's Role in Health Insurance

The use of AI in health insurance is not merely a speculative future scenario; it is currently a reality that impacts millions of Americans. According to a recent survey by the National Association of Insurance Commissioners (NAIC), 84% of health insurers are utilizing AI or machine learning technologies in some capacity. Notably, 12% of these insurers apply AI specifically in the process of denying prior authorizations for treatments, a critical step in determining whether a patient will receive coverage for prescribed care.

However, the increasing reliance on these technologies raises concerns about transparency and accountability. The same NAIC survey revealed that nearly a third of health insurers do not consistently test their AI models for bias or discrimination, despite the association's guidance recommending such practices since late 2023. This lack of oversight could lead to unfair treatment of certain patient populations, particularly those already marginalized within the healthcare system.

The Impact of AI on Claims Denials

The implications of AI on claims processing are stark. A recent analysis by the Kaiser Family Foundation (KFF) found that fewer than 1% of denied Affordable Care Act claims were appealed in 2023, with insurers upholding 56% of the denials that were challenged. This statistic underscores a troubling trend: even when patients attempt to contest denials, the likelihood of overcoming an insurer's decision is alarmingly low.

Case Studies on AI in Claims Management

One particularly concerning case is the federal lawsuit against Cigna, referred to as Kisting-Leung v. Cigna. The complaint alleges that Cigna's PxDx algorithm denied over 300,000 claims within a two-month period in 2022, with an average review time of just 1.2 seconds per claim. This raises critical questions about the thoroughness and fairness of AI-driven decision-making in healthcare. Cigna has responded by asserting that the PxDx algorithm is not AI-powered and applies to a limited subset of claims, yet the case has been allowed to proceed, reflecting the legal complexities surrounding AI use in the industry.

Other major players, including UnitedHealthcare and Humana, are facing similar litigation challenges, emphasizing that the stakes are high for health insurers using AI technologies. Not only do these situations pose legal risks, but they also jeopardize patient trust and satisfaction.

Legislative Responses to AI in Insurance

The regulatory landscape surrounding AI in health insurance is evolving. In January 2025, California implemented the Physicians Make Decisions Act, which prohibits insurers from denying medically necessary care based solely on algorithmic decisions. This legislation mandates that a licensed human review such denials, aiming to enhance the accountability of AI systems and protect patient interests.

Moreover, nearly 30 states have adopted various versions of the NAIC's model bulletin on AI governance, and the NAIC has rolled out its AI Systems Evaluation Tool in 12 states since March 2026, with plans for a nationwide expansion. This tool is designed to help insurers assess their AI models for compliance with ethical standards, thereby promoting better governance and fostering greater transparency in AI applications.

The Federal vs. State Regulatory Debate

Despite these advancements at the state level, a significant pushback has emerged from federal authorities. After the White House issued an executive order on AI in December 2025, the NAIC expressed concerns that the order introduces legal uncertainties that could hinder the insurance market. The NAIC has called for a reaffirmation of state authority over AI governance in insurance, emphasizing that a cohesive regulatory framework is crucial for both insurers and consumers.

The Future of AI in Health Insurance

As health insurers increasingly deploy AI in utilization review and claims management, the need for robust governance frameworks becomes paramount. With nearly a third of health insurers not regularly testing their models for bias, the urgency to document governance processes intensifies. The upcoming full national rollout of the NAIC's evaluation tool will likely serve as a critical checkpoint for insurers as they navigate the complexities of AI deployment.

For consumers, it is essential to remain informed about how these technologies impact their healthcare decisions. Understanding the mechanisms behind claims denials and the potential for biases in AI systems can empower patients to advocate for their rights and seek necessary care.

Key Takeaways

• AI is increasingly used in health insurance, with 84% of insurers employing it in some capacity.
• A significant portion of health insurers do not regularly test their AI models for bias or discrimination.
• Legal challenges against insurers highlight the potential risks associated with AI-driven claims decisions.
• State-level regulations are evolving to ensure accountability in AI applications within health insurance.
• Consumers should stay informed about their rights and the implications of AI in their healthcare.

Frequently Asked Questions

How does AI impact claims processing in health insurance?

AI is increasingly utilized by health insurers to streamline claims processing, often assessing claims for approval or denial based on predetermined algorithms. While this can lead to quicker decisions, it raises concerns about fairness and transparency, particularly when algorithms may not account for individual patient circumstances or biases in the data.

What regulations are in place to govern AI use in health insurance?

Regulations vary by state, but many have begun implementing guidelines that require health insurers to ensure their AI systems are tested for bias and provide human oversight in decision-making processes. The NAIC has introduced an AI Systems Evaluation Tool to promote compliance and transparency in how AI is applied within the industry.

What can consumers do if their claims are denied due to AI decisions?

Consumers have the right to appeal claims denials, although the success rate for appeals is notably low. It is crucial for patients to understand their insurance policies, keep thorough records of their communications with insurers, and seek assistance from patient advocacy groups if they encounter challenges in getting necessary medical care.

What is the significance of the Cuban-Andreessen debate on AI?

The public debate between Mark Cuban and Marc Andreessen highlights the broader implications of AI in healthcare, particularly concerning how these technologies can influence patient care and insurance practices. Their exchange underscores the need for ongoing scrutiny and regulation to ensure that AI serves to enhance, rather than hinder, patient access to necessary medical services.